Methylmalonic acid Refered Test
Back to main menuEurofins Biomnis code
MALON
Clinic significance
Methylmalonic acid is an intermediate in the conversion of propionic acid into succinic acid for use in the Krebs cycle.Urine levels are increased in pernicious anemia and methylmalonicacidemia which is characterized by neurological distress without convulsions (manifesting either immediately following birth or later), acidosis, ketosis and sometimes hyperlactacidemia with hyperammonemia and hyperglycinemia.
Prenalytics
- 2 mL
- heparinised plasma (do not use tubes with gel separators)
- FROZEN
Further information
- 1 individual aliquot for this analysis.
- Fasting sample
- Sample to be frozen within 1 hour. Home sampling is not advisable.
- Enclose the specific clinical information form (R26-INTGB : Metabolic Biochemistry)
Documents to download
Methodology
Gas Phase Chromatography / Mass Spectrometry (GC-MS)
Turnaround time
1 month
Pathologist(s) in charge
Refered Test
Specialty
Analytical Chemistry
Contact(s)
Dr Gilles PANTEIX
E-mail(s)
Phone(s)
+334 72 80 10 41
Caption
Refered TestThe pre-analytical conditions and prices are defined on the basis of the requirements of the performing laboratory.
